Evidence-Based Complementary and Alternative Medicine

Pharmacological Potential of Natural Products Against Cardiovascular Diseases


Publishing date
01 Jan 2023
Status
Closed
Submission deadline
19 Aug 2022

1Lahore College for Women University (LCWU), Lahore, Pakistan

2Princess Nourah Bint Abdul Rahman University, Riyadh, Saudi Arabia

3Shaheed Benazir Bhutto University, Sheringal, Pakistan

4University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania

This issue is now closed for submissions.

Pharmacological Potential of Natural Products Against Cardiovascular Diseases

This issue is now closed for submissions.

Description

From time immemorial, plant extracts and bioactive compounds isolated from plants have been used for cardiovascular health. The wide variety of biologically active compounds isolated from plants for many centuries is being used as crude material or as pure compounds for treating various cardiovascular diseases. Cardiovascular diseases (CVD) are one of the leading causes of mortality and incapacity worldwide. Medication therapy options will vary depending on the particular type of CVD. Many patients are intolerant of the therapeutic options available. On this premise, the emerging need for new drug options is highlighted, where those obtained from medicinal plants stand out, which are immeasurable sources of thousands of secondary metabolites with significant therapeutic potential.

Until a few decades ago, medicinal plants were used with impressively little knowledge about their actual properties. In most cases, the biological role of plant extracts and phyto-compounds is not really known. However, now studies are oriented towards an in-depth analysis of the valuable compounds in these plants which can be used for treating CVD and knowledge about their mechanism of action.

The rationalization of ethnomedicinal uses of plants is an important area of research in complementary and alternative medicine. This Special Issue encourages scholarly work indicating the mechanism of action of plant extracts and compounds present in these extracts against cardiovascular diseases. This Special Issue aims to collect original research and review articles regarding research into plant extracts, and bioactive compounds used against cardiovascular ailments.

Potential topics include but are not limited to the following:

  • Assessment of pharmacological properties of plants against cardiovascular diseases
  • In-vitro studies about the evaluation of plant extracts and bioactive compounds against cardiovascular diseases
  • In-silico studies of bioactive compounds against cardiovascular diseases
  • Plant-derived nanomaterials against cardiovascular diseases
  • Identification and characterization of phytochemicals from medicinal plants used around the world against cardiovascular diseases
  • Systematic reviews and meta-analyses on the potential of plant-based remedies for treating cardiovascular diseases
  • Basic research - in vivo and in vitro study, network pharmacology study, bioinformatics study, and pre-clinical research for treating cardiovascular diseases
  • Critical reviews of the historical, clinical, and legal status of medicinal plants used in the management of cardiovascular diseases

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 8825540
  • - Research Article

[Retracted] Clinical Significance of Inflammatory Factors, Osteocalcin, and Matrix Metalloproteinase-8 in Gingival Crevicular Fluid in Drug Treatment of Severe Periodontitis

Jinxing Gao | Wenjun Shui | Lei Ren
  • Special Issue
  • - Volume 2022
  • - Article ID 6561721
  • - Research Article

[Retracted] Establishment and Evaluation of Artificial Intelligence-Based Prediction Models for Chronic Kidney Disease under the Background of Big Data

Xiaoqian Yan | Ximin Li | ... | Gang Hu
  • Special Issue
  • - Volume 2022
  • - Article ID 5943322
  • - Research Article

[Retracted] Glycyrrhizic Acid Inhibits Core Fucosylation Modification Modulated EMT and Attenuates Bleomycin-Induced Pulmonary Fibrosis

Lili Gao | Nan Wang | ... | Taihua Wu
  • Special Issue
  • - Volume 2022
  • - Article ID 9454843
  • - Research Article

[Retracted] Role and Mechanism of Epithelial-Mesenchymal Transition Mediated by Inflammatory Stress-Induced TGF-β1 in Promoting Arteriovenous Fistula Stenosis

Qingqing Duan | Xiaogang Shen | ... | Xiaohui Xie
  • Special Issue
  • - Volume 2022
  • - Article ID 5741198
  • - Review Article

[Retracted] Prevention and Treatment of Cardiovascular Diseases with Plant Phytochemicals: A Review

Rakesh Kumar Bachheti | Limenew Abate Worku | ... | Archana Bachheti
  • Special Issue
  • - Volume 2022
  • - Article ID 1681038
  • - Research Article

[Retracted] Effect of Radical Laparoscopic Surgery and Conventional Open Surgery on Surgical Outcomes, Complications, and Prognosis in Elderly Patients with Bladder Cancer

Jiangang Chen | Zhibo Gu | ... | Donghua Gu
  • Special Issue
  • - Volume 2022
  • - Article ID 1889628
  • - Research Article

[Retracted] Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis

Hui Zhang | Jianchun Xian | ... | Lu Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 6245647
  • - Research Article

[Retracted] FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway

Minghui Li | Zhiming Gao | ... | Zhanshu Ma
  • Special Issue
  • - Volume 2022
  • - Article ID 4156330
  • - Research Article

[Retracted] Protective Effects and Molecular Mechanism of Total Flavonoids from Lycium Barbarum Leaves on Photoaged Human Dermal Fibroblasts

Fei Song | Lihua Wang | ... | Huisheng Ma
  • Special Issue
  • - Volume 2022
  • - Article ID 1659860
  • - Research Article

[Retracted] Establishment and Evaluation of Influencing Factors and Risk Prediction Model of Severe Neonatal Hyperbilirubinemia Complicated with Acute Bilirubin Encephalopathy

Shanshan Jiang | Xiaoxiao Li | ... | Tao Qin
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.